4.1 Review

'Goal-directed extracorporeal circulation: transferring the knowledge and experience from daily cardiac surgery to extracorporeal membrane oxygenation'

期刊

PERFUSION-UK
卷 38, 期 3, 页码 449-454

出版社

SAGE PUBLICATIONS LTD
DOI: 10.1177/02676591211063826

关键词

goal-directed therapy; goal-directed perfusion; extracorporeal membrane oxygenation; cardiopulmonary bypass; acute kidney; injuries; end-organ protection

向作者/读者索取更多资源

Metabolism management plays a crucial role in extracorporeal technologies, and the most commonly used metabolic targets are indexed oxygen delivery and cardiac index. There are differences in scientific evidence and metabolic management between extracorporeal membrane oxygenation (ECMO) and cardiopulmonary bypass (CPB). In this context, we review the strategies for optimal goal-directed therapy during CPB and ECMO.
Metabolism management plays an essential role in extracorporeal technologies. There are different metabolic management devices integrated to extracorporeal devices; the most commonly used and accepted metabolic target in adult patients is indexed oxygen delivery (280 mL/min/m(2)) and cardiac index (2.4 L/min/m(2)), which can be managed independently or according to other metabolic parameters. Extracorporeal membrane oxygenation (ECMO) is a temporary form of life support providing a prolonged biventricular circulatory and pulmonary support for patients experiencing both pulmonary and cardiac failure unresponsive to conventional therapy. The goal-directed perfusion initiative during cardiopulmonary bypass (CPB) reduced the incidence of acute kidney injury after cardiac surgery. On the basis of the available literature, the identified goals to achieve during CPB include maintenance of oxygen delivery > 300 mL O-2/min/m(2) and reduction in vasopressor use. ECMO and CPB are conceptually similar but differ in many aspects and finality; in particular, they differ in the scientific evidence for metabolic management nadirs. As for CPB, predictive target parameters have been found and consolidated, particularly in terms of acute renal injury and the prevention of anaerobic metabolism, while for ECMO management, a blurred path remains. In this context, we review the strategies for optimal goal-directed therapy during CPB and ECMO, trying to transfer the knowledge and experience from daily cardiac surgery to veno-arterial ECMO.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.1
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据